KIR4.1 antibodies as biomarkers in multiple sclerosis

KIR4.1 antibodies as biomarkers in multiple sclerosis

Bibliographic Details
Main Authors:	Marie eWunsch, Damiano eRovituso, Stefanie eKuerten
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-04-01
Series:	Frontiers in Neurology
Subjects:	Autoantibodies multiple sclerosis (MS) CNS antigen epiphenomenon KIR4.1 parietal cells
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fneur.2014.00062/full

Similar Items

Kir4.1 Dysfunction in the Pathophysiology of Depression: A Systematic Review
by: Stefania Della Vecchia, et al.
Published: (2021-10-01)

Herpesvirus Infections in KIR2DL2-Positive Multiple Sclerosis Patients: Mechanisms Triggering Autoimmunity
by: Daria Bortolotti, et al.
Published: (2022-02-01)

Oligodendrocyte-encoded Kir4.1 function is required for axonal integrity
by: Lucas Schirmer, et al.
Published: (2018-09-01)

Embracing Suffering: Unraveling 19th-Century Philosophical Perspectives Amidst Historical and Cultural Changes
by: Kristoff RADU
Published: (2024-03-01)

Antibodies to myelin lipids in multiple sclerosis
by: M. V. Ivanova, et al.
Published: (2017-02-01)

Kir4.1 channel activation in NG2 glia contributes to remyelination in ischemic strokeResearch in context
by: Xiaoqi Hong, et al.
Published: (2023-01-01)

Increased potassium excretion in children with monosymptomatic nocturnal enuresis: could it be related to Kir 4.1- KCNJ10 gene polymorphism?
by: Ayşe Balat, et al.
Published: (2020-04-01)

Ketamine Reduces the Surface Density of the Astroglial Kir4.1 Channel and Inhibits Voltage-Activated Currents in a Manner Similar to the Action of Ba<sup>2+</sup> on K<sup>+</sup> Currents
by: Mićo Božić, et al.
Published: (2023-05-01)

KIR2DL4 (CD158d): An activation receptor for HLA-G
by: Sumati eRajagopalan, et al.
Published: (2012-08-01)

Program Pembinaan Intensif Guru Pembina dan Siswa Ekstrakurikuler KIR di SMP/MTs Kabupaten Malang Berbasis Hasil Penelitian
by: M Muchson, et al.
Published: (2022-05-01)

HLA and KIR genetic association and NK cells in anti-NMDAR encephalitis
by: Vicente Peris Sempere, et al.
Published: (2024-07-01)

Novel Approach to Cell Surface Discrimination Between KIR2DL1 Subtypes and KIR2DS1 Identifies Hierarchies in NK Repertoire, Education, and Tolerance
by: Jean-Benoît Le Luduec, et al.
Published: (2019-04-01)

Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes
by: Aimee L. Hanson, et al.
Published: (2022-06-01)

Sildenafil affects the human Kir2.1 and Kir2.2 channels at clinically relevant concentrations: Inhibition potentiated by low Ba2+
by: Akimasa Iijima, et al.
Published: (2023-02-01)

Blood‐brain barrier dysfunction and decreased transcription of tight junction proteins in epileptic dogs
by: Erez Hanael, et al.
Published: (2024-07-01)

KIR2DS2+ NK cells in cancer patients demonstrate high activation in response to tumour-targeting antibodies
by: Lara V. Graham, et al.
Published: (2024-09-01)

KIR Receptors as Key Regulators of NK Cells Activity in Health and Disease
by: Joanna Dębska-Zielkowska, et al.
Published: (2021-07-01)

Curriculum Evaluation: CIPP Model of the Youth Scientific Group (KIR) extracurricular
by: Diah Ambarumi Munawaroh, et al.
Published: (2022-05-01)

Patients Lacking a KIR-Ligand of HLA Group C1 or C2 Have a Better Outcome after Umbilical Cord Blood Transplantation
by: Carmen Martínez-Losada, et al.
Published: (2017-07-01)

KIR And HLA Haplotype Analysis in a Family Lacking The KIR 2DL1-2DP1 Genes
by: Vojvodić Svetlana, et al.
Published: (2015-06-01)

Diyabet İndüklenmiş Sıçan Aortası ATP\'ye Duyarlı Potasyum Kanallarının, Kir 6.1 ve Kir 6.2, Pulslu Manyetik Alan Tedavisi ile Regülasyonu
by: Mehmet Bertan YILMAZ, et al.
Published: (2013-03-01)

Capillaroscopy and Immunological Profile in Systemic Sclerosis
by: Sevdalina Nikolova Lambova, et al.
Published: (2022-03-01)

Characterization of a novel variant in KCNJ16, encoding Kir5.1 channel
by: Biyang Xu, et al.
Published: (2024-10-01)

Differential regulation of diabetes-induced rat aorta ATP-sensitive potassium channels, Kir 6.1 and Kir 6.2, by pulsed magnetic field therapy
by: Mehmet Bertan Yilmaz, et al.
Published: (2013-02-01)

The Novel Cytokine Interleukin-41/Meteorin-like Is Reduced in Diffuse Systemic Sclerosis
by: Paul Freedman, et al.
Published: (2024-07-01)

Autoantibodies in systemic sclerosis: From disease bystanders to pathogenic players
by: Aurélien Chepy, et al.
Published: (2025-06-01)

The role of consciousness in evolutionary history: An epiphenomenon or a decisive adaptive factor in natural selection
by: Pronin, Konstantin Vladimirovich
Published: (2022-03-01)

Abundant CpG-sequences in human genomes inhibit KIR3DL2-expressing NK cells
by: Jason Pugh, et al.
Published: (2021-11-01)

Oligodendrocytes control potassium accumulation in white matter and seizure susceptibility
by: Valerie A Larson, et al.
Published: (2018-03-01)

Autoantibody Profile in Systemic Sclerosis
by: Fatemeh Behmanesh, et al.
Published: (2010-02-01)

KIR3DL05 and KIR3DS02 Recognition of a Nonclassical MHC Class I Molecule in the Rhesus Macaque Implicated in Pregnancy Success
by: Rachel E. Nicholas, et al.
Published: (2022-03-01)

Systemic sclerosis and the gastrointestinal tract
by: Irena Walecka
Published: (2017-09-01)

AUTOANTIBODIES IN SYSTEMIC SCLEROSIS: SPECTRUM, CLINICAL ASSOCIATIONS, AND PROGNOSTIC VALUE
by: L. P. Ananyeva, et al.
Published: (2016-03-01)

Immunomodulatory Treatment Impact on IVF Outcomes in KIR AA Genotype: Personalized Fertility Insights
by: Luana Seles, et al.
Published: (2024-06-01)

Chloroquine Decreased Kir6.2 Immunoreactivity in Chronic Hypoxic Heart
by: Arda Kaan ÜNER, et al.
Published: (2022-04-01)

Specific Autoantibodies and Microvascular Damage Progression Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: Are There Peculiar Associations? An Update
by: Elvis Hysa, et al.
Published: (2023-01-01)

Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation
by: Davood Jafari, et al.
Published: (2017-06-01)

The Role of Mesenchymal Stem Cells in Modulating Adaptive Immune Responses in Multiple Sclerosis
by: Sepehr Dadfar, et al.
Published: (2024-09-01)

Presence of KIR2DL2/S2, KIR2DL5, and KIR3DL1 Molecules in Liver Transplant Recipients with Alcoholic Cirrhosis Could Be Implicated in Death by Graft Failure
by: Raquel Morales, et al.
Published: (2023-03-01)

Associations of autoantibodies and clinical profile of the patients with systemic sclerosis
by: Shahin Mahmud, et al.
Published: (2022-09-01)